Abstract
We observed a neonate who had severe thrombocytopenia wherein evaluations for neonatal immune-mediated thrombocytopenia and congenital infections were negative, and the marrow findings were consistent with congenital amegakaryocytic thrombocytopenia (CAMT). A genomic microarray identified a microdeletion at 21q22.11 including the gene RUNX1. Two somewhat similar cases were recently reported, but with multiple congenital anomalies that are not present in our case. We propose that a 21q22 deletion resulting in RUNX1 haploinsufficiency can produce a phenotype similar to CAMT with various associated anomalies depending on which adjacent genes are absent or disrupted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bussel JB . Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009; 7 (Suppl 1): 253–257.
Bussel JB, Sola MC . Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 2009; 33: 35–42.
Consolini DM . Thrombocytopenia in infants and children. Pediatr Rev 2011; 4: 135–151.
Shinawi M, Erez A, Shardy DL, Lee B, Naeem R, Weissenberger G et al. Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdelections on chromosome 21q. Blood 2008; 112: 1042–1047.
Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. Haploinsufficiency of CFBA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166–175.
Shiba N, Hasegawa D, Park MJ, Murata C, Matsubara A, Ogawa C et al. CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML). Blood 2012; 119 (11): 2612–2614.
Rio-Machin A, Menezes J, Maiques-Diaz A, Agirre X, Ferreira BI, Acquadro F et al. Abrogation of RUNX1 gene expression in de novo myelodysplastic syndrome with t(4;21)(q21;q22). Haematologica 2012; 97 (4): 534–537.
Click ES, Cox B, Olson SB, Grompe M, Akkari Y, Moreau LA et al. Fanconi anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene. Am J Med Genet A 2011; 155A (7): 1673–1679.
Christensen RD, Henry E, Jopling J, Wiedmeier SE . The CBC: reference ranges for neonates. Semin Perinatol 2009; 33 (1): 3–11.
Lindstrand A, Malmgren H, Sahlén S, Schoumans J, Nordgren A, Ergander U et al. Detailed molecular and clinical characterization of three patients with 21q deletions. Clin Genet 2010; 77 (2): 145–154.
Hedley PL, Haundrup O, Andersen PS, Aidt FH, Jensen M, Moolman-Smook JC et al. The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study. J Negat Results Biomed 2011; 10: 12–13.
Ballmaier M, Germeshausen M . Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost 2011; 37 (6): 673–681.
Geddis AE . Congenital amegakaryocytic thrombocytopenia. Pediatr Blood Cancer 2011; 57 (2): 199–203.
Katzaki E, Morin G, Pollazzon M, Papa FT, Buoni S, Havek J et al. Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: report of three patients. Am J Med Genet A 2010; 152A (7): 1711–1717.
Click ES, Cox B, Olson SB, Grompe M, Akkari Y, Moreau LA et al. Fanconi anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene. Am J Med Genet A 2011; 155A: 1673–1679.
Melis D, Genesio R, Cappuccio G, MariaGinocchio V, Casa RD, Menna G et al. Mental retardation, congenital heart malformation, and myelodysplasia in a patient with a complex chromosomal rearrangement involving the critical region 21q22. Am J Med Genet A 2011; 155A (7): 1697–1705.
Aneja K, Jalagadugula G, Mao G, Singh A, Rao AK . Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 gene is a transcriptional regulator of PF4. J Thromb Haemost 2011; 9 (2): 383–391.
Jalagadugula G, Mao G, Kaur G, Goldfinger LE, Dhanasekaran DN, Rao AK . Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency. Blood 2010; 116 (26): 6037–6045.
Geddis AE . A POTEntial new gene for thrombocytopenia. Blood 2011; 117: 6406–6407.
Sola MC, Slayton WB, Rimsza LM, Perez JA, Fuchs D, Calhoun DA et al. A neonate with severe thrombocytopenia and radio-ulnar synostosis. J Perinatol 2004; 24 (8): 528–530.
Baer VL, Lambert DK, Henry E, Christensen RD . Severe thrombocytopenia in the NICU. Pediatrics 2009; 124 (6): e1095–e1100.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Christensen, R., Wiedmeier, S. & Yaish, H. A neonate with congenital amegakaryocytic thrombocytopenia associated with a chromosomal microdeletion at 21q22.11 including the gene RUNX1. J Perinatol 33, 242–244 (2013). https://doi.org/10.1038/jp.2012.53
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jp.2012.53


